Repeated PCR in CML during IFN-α therapy

A. M. Liberati, E. Donti, C. Rosso, F. Lo Coco, F. Dore, S. Pardini, S. Cocco, M. Addis, G. Saglio

Research output: Contribution to journalArticlepeer-review


Repeated PCR analysis was performed on bone marrow and or peripheral blood samples from 4 CML patients in complete cytogenetic remission during treatment with IFN-α. Two patients became PCR-negative. One was negative for the analyses carried out from the 9th to the 30th months, but reverted to PCR positivity 10 months after IFN was reduced from 1.5 x 106 IU/day to 1 x 106 IU and given on alternate days. Although the dose was again raised to 3 x 106 IU/day, 8 months later her peripheral blood cells were still PCR- positive, but remained persistently Ph'-negative. Another patient became PCR- negative at the 42nd month and remained so at the last analysis performed 3 months later. Two patients were persistently PCR-positive. Cytogenetic relapse was documented in both, in one while still on full therapy. Ph'- positive metaphases reappeared in the other patient 7 months after discontinuing IFN-α therapy.

Original languageEnglish
Pages (from-to)152-155
Number of pages4
JournalEuropean Journal of Haematology
Issue number3
Publication statusPublished - 1994


  • CML
  • IFN-α
  • PCR

ASJC Scopus subject areas

  • Hematology


Dive into the research topics of 'Repeated PCR in CML during IFN-α therapy'. Together they form a unique fingerprint.

Cite this